AAOM Virtual Scientific Meeting Schedule

Oral Medicine: The Unstoppable Dedication to the Mission

All sessions are listed in Pacific Time.*

Event Home



Fri. July 24
Sat. July 25


About the Schedule

The AAOM Virtual Scientific Meeting will be held over the course of two days, beginning each day at 7:00 AM (PT) and going until around 2:00 PM (PT). The Virtual Scientific Meeting schedule is subject to change.

Friday, July 24, 2020

Time (Pacific Time) Discussion
7:00 AM – 7:15 AM Opening Speech: AAOM President Dr. Lauren Patton
7:15 AM – 8:00 AM

Opening Lecture: Oral Medicine Specialty Recognition: The Turning Point!
* Craig S. Miller, DMD
Moderator: Arwa Farag

On March 2, 2020, the Board of the National Commission on Recognition of Dental Specialties and Certifying Boards has voted in favor of specialty recognition of Oral Medicine. Herein, Oral Medicine has become the 11th ADA recognized dental specialty!

This talk provides an overview for the efforts put over the past decades to achieve specialty recognition and discusses the influence of specialty status on the future of oral medicine.


  1. Understand the history behind specialty recognition
  2. Recognized the efforts of those who worked with dedication to achieve this goal.
  3. Discuss the influence of specialty recognition on the future of oral medicine.
8:00 AM – 8:30 AM Break
8:30 AM – 10:00 AM Plenary 1: Saliva in the Age of High-Throughput Technology
Moderator: David Dean
8:30 AM – 9:05 AM

The Role of the Microbiome in Oral Cancer
Jorge Frias-Lopez, PhD, University of Florida

The oral microbiome plays a potential role in the pathogenesis of cancer. This talk discusses the mechanisms that many influence the oncogenic and mutagenic changes in the oral tissues and lead to the subsequent development of oral cancer.

Learning Objectives:

  1. Discuss the mechanisms in which the oral microbiota may influence the pathogenesis of oral cancer.
  2. Display the current studies that characterize the profiles of gene expression of the microbial communities colonizing active cancer sites by metatranscriptome analysis.
  3. Illustrate how potentially can the oral microbiome be harnessed to prevent oncogenic and mutagenic changes in the oral tissues. 
 9:05 AM – 9:40 AM

Restoring Salivary Glands Function with Gene Transfer Therapy: Turning the Impossible into Reality
Michael Passineau, PhD, Allegheny Health Network

Permanent destruction of salivary glands is one of the significant negative consequence of head and neck radiation therapy and Sjögren syndrome that is tied to a variety of critical oral health issues. This talk sheds light on the promising approach of gene transfer therapy to restore damaged salivary glands.

Learning Objectives:

  1. Describe the fundamental concepts of salivary glands gene therapy.
  2. Discuss the various techniques of salivary glands gene transfer in both in vitro and in vivo studies.
  3. Demonstrate the future directions and the applicability of translating this treatment modality to randomized clinical trials.
 9:40 AM – 10:00 AM Live Panel Discussion with Speakers
10:00 AM – 11:00 AM Break
11:00 AM – 1:05 PM Oral Medicine Practice Session 1: Clinical "Red Flags" in Oral Medicine?
Moderator: Joel Napenas
11:00 AM – 11:35 PM

Alarming Findings in Head and Neck Imaging: Never Turn a Blind Eye
Dania Tamimi, BDS, DMSc

Head and neck imaging studies provide tremendous details, some of which can be alarming and may be easily overlooked by clinicians.  Detection of these findings can contribute to early diagnosis and improved treatment outcomes. 

Learning objectives:

  1. Understand the fundamental principles of imaging in patients with head and neck pathology.
  2. Become familiar with the radiographic interpretation of advanced imaging studies for head and neck diseases.
  3. Highlight potentially alarming imaging findings that require immediate medical attention.
 11:35 AM – 12:10 PM

Pharmacotoxicity: How and When to Stop?
Lori Reisner, PharmD, FCSHP, University of California, San Francisco Medical Center

The practice of oral medicine is heavily invested in prescribing medications. This talk highlights the major side effects of medications prescribed in oral medicine and provides clinical pearls for how to monitor the use of these medications and identify alerting signs of pharmacotoxicity. 

Learning objectives:

  1. Understand the fundamental principles of pharmacotoxicity.
  2. Become familiar with pharmaceutical considerations that impact the management of oral medicine patients.
  3. Gain an appreciation for the role of medication-related side effects in oral medicine practices.
 12:10 PM – 12:45 PM

Identifying the Red Flags in Your Patient's Behavior
Ronald Kulich, PhD, Tufts University School of Dental Medicine

Oral medicine patients may suffer from chronic debilitating conditions. This may negatively impact their physical, psychological, emotional and economic status and lead to serious and harmful consequences.  This talk emphasizes the alerting signs in patients’ behavior and guides clinicians on how to detect and deal with these red flags.

Learning Objectives

  1. Highlight the most common red flags in patient’s behavior that might be tied to harmful consequences such as suicidal ideation, drug seeking behavior, litigation, etc..
  2. Provide guidance on how to detect and confirm the existence of these concerning behaviors/ideations.
  3. Illustrate the prompt action practitioners should take to contain this behavior and prevent its consequences.
 12:45 PM – 1:05 PM Live Panel Discussion with Speakers 

Saturday, July 25

Time (Pacific Time) Discussion
7:00 AM – 8:30 AM Plenary 2: Oral Medicine and Technology: Back to the Future
Moderator: Jennifer Frustino and/or Chelsia Sim
7:00 AM – 7:35 AM

Dental Bioinformatics in Oral Medicine
Srikar Chamala, PhD, University of Florida College of Medicine

Bioinformatics created a steady stream of large and complex data, which has transformed the way clinical are basic science researches are conducted. It has played a pivot role in biomedical research and has been gaining momentum in dental medicine.

Learning Objectives:

  1. Familiarize with bioinformatics tools for large data modeling, prediction, and optimization.
  2. Learn current clinical and basic science research informatics projects and innovations that can aid in the molecular understanding of the genes and proteins, and their interactions, pathways, and networks.
  3. Discuss the implications of bioinformatics in oral medicine research. 
7:35 AM – 8:10 AM

Artificial Intelligence: Revolutionizing Healthcare Delivery
* Tarik Alkasab, MD, PhD

Artificial intelligence (AI) has the potential to revolutionize the practice of medicine and dentistry with a significant change in the role of physicians and dentists.  This talk provides a practical, real world approach to the artificial intelligence and automated processes in the diagnosis and management of patients.

Learning Objectives:

  1. Introduce the concept of AI and how it is currently used in healthcare.
  2. Familiarize with artificial intelligence applications in oral medicine and dentistry.
  3. Discuss the pros and cons of the utilization of AI in health care.
  • This session not available for self-study/on-demand
8:10 AM – 8:30 AM Live Panel Discussion with Speakers
8:30 AM – 9:00 AM Break
9:00 AM – 10:30 PM Oral Medicine Practice Session 2: Oral Medicine and the COVID-19 Pandemic
Moderator: Herve Sroussi
9:00 AM – 9:35 AM

Impact of COVID-19 on Oral Medicine Practice: How to Salvage the Current Crisis
Nathaniel Treister, DMD, DMSc, Harvard School of Dental Medicine; Brigham and Women's Hospital

Practitioners in the field of Oral Medicine are in charge of delivering care to patients with significant medical complexities that, if remained undiagnosed/unmanaged, can lead to increased risk of morbidity and mortality. This talk will explore the impact of the COVID-19 pandemic on the clinical practice of Oral Medicine and highlights the strategies adopted to salvage the current circumstances and maintain the continuity of patients’ care.

Learning Objectives:

  1. Illustrate the impact of the current COVID-19 crisis on care delivery for patient with significant medical complexities seen at the oral medicine clinic.
  2. Display the essential modifications in care-delivery methods including the utilization of telemedicine to salvage the current circumstances.
  3. Discuss the use of alternative care-delivery modalities in the post-pandemic era.
 9:35 AM – 10:10 AM

Telemedicine: The Nuts and Bolts for Coding and Billing
Rose Nierman, RDH, Nierman Practice Management

The practice of oral medicine consists chiefly of the management of patients with complex medical disorders involving the oral mucosa, salivary glands, temporomandibular joint and other orofacial structures. With the recent increase in the use of telemedicine for patients’ care delivery, many questions are emerging in regard to credentialing/licensing requirements, billing, coding, and reimbursement.

Learning objectives:

  1. Provide an overview for the legal, regulatory, and licensure requirements for the utilization of telemedicine.
  2. Demonstrate the variability of coding/cross-coding among insurance carriers.
  3. Highlight the billing and reimbursement issues providers may encounters when using telemedicine.
10:10 AM – 10:30 AM Live Panel Discussion with Speakers
10:30 AM – 11:30 AM Break
11:30 AM – 1:00 PM Clinicopathologic Expert Panel
Moderators: Cesar Migliorati and Alessandro Villa

11:30 AM – 1:00 PM*

*This session is split between three topics. Specific times are listed in the session description at the bottom.

New Oral Complications with Immune Check-Point Inhibitors in Cancer Care: An Interactive Case-Based Discussion

This clinico-pathologic session is centered around new oral complications in cancer patients receiving immune check-point inhibitors. A complex clinical case will be presented by a panel of experts in oral medicine, oral pathology, and radiation oncology. The case presentation will include the patient’s medical history, clinical presentation, diagnostic studies, treatment modalities, and research protocol considerations. Ample time will be designated for more interaction between the audience and the experts’ panel at the end of the clinical case presentation. 

11:30 AM – 12:00 PM
Oral Medicine:
* Cesar Migliorati, DDS, MS, PhD, UF College of Dentistry

Learning Objectives

  1. To present a case of an immune-related adverse event in the oral cavity associated with an immune check-point inhibitor in a cancer patient
  2. To discuss the clinical evolution of the case from the time the oral manifestations were diagnosed
  3. To present the treatment modalities instituted and how the patient responded to therapy
  4. To set the stage for further discussion by the panel members
12:00 PM – 12:30 PM

Oral and Maxillofacial Pathology
Indraneel Bhattacharyya, BDS, DDS, MS, University of Florida

Literature review of other oral adverse effects of immune checkpoint inhibitors

Learning Objectives

  1. Presentation of a case of severe oral erosive lichenoid reaction to pembrolizumab therapy
  2. Brief discussion of the immune check point inhibitors
  3. Briefly discuss treatment options

12:30 PM – 1:00 PM

Radiation Oncology: 
Allison Grow, MD, PhD, North Florida Radiation Oncology

Learning Objectives

  1. Response of malignancies to treatment is strongly immune modulated
  2. Two conditions are required: The immune system must be active in the tumor microenvironment, and the innate brakes on the immune system must be released
  3. Radiotherapy is one means of activating the immune system in the TME (and systemically)
  4. Immune checkpoint inhibitor therapy is one means of releasing the innate brakes
  5. The combination of these two treatments may lead to powerful antitumor effects AND unpredictable toxicities, including outside the radiotherapy field
1:00 PM – 1:20 PM
Live Panel Discussion with Speakers
1:20 PM – 1:30 PM
Closing Remarks
AAOM President Dr. Lauren Patton
1:30 PM – 1:40 PM Announcement of the 2020 AAOM Fall Meeting in Philadelphia and the 2021 Spring Meeting in Seattle, Washington.
Dr. Craig Hatch, Chair of the National Meeting Committee

American Academy of Oral Medicine (AAOM) is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. AAOM designates this 2-day live activity for up to 8.75 continuing education credits. AAOM designates the on-demand/self-study activity for up to 8 continuing education credits.

Note: Speaker with a "*" next to their name have provided information relative to conflict of interest/financial disclosures. See the Speaker bio page for details.  No other relevant commercial financial relationships exist for the planner and speakers of the above-noted program.